Repeated Cranial and Large‐Vessel Positron Emission Tomography/Computed Tomography Scans and the Association With Structural Aortic Disease in Giant Cell Arteritis: A Five‐Year Observational Study

Objective Giant cell arteritis (GCA) is characterized by cranial ischemia at diagnosis and late aortic structural disease. Repeated combined cranial and large‐vessel fluoro‐2‐deoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) scans were performed to assess the distributio...

Full description

Saved in:
Bibliographic Details
Main Authors: Anthony M. Sammel, Ivan Ho Shon, Daniel A. Moses, Stacey Fredericks, Gita Mathur, Claudia M. Hillenbrand, Edward Hsiao, Geoffrey Schembri, Rodger Laurent, Eva A. Wegner
Format: Article
Language:English
Published: Wiley 2025-03-01
Series:ACR Open Rheumatology
Online Access:https://doi.org/10.1002/acr2.70006
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850259005411164160
author Anthony M. Sammel
Ivan Ho Shon
Daniel A. Moses
Stacey Fredericks
Gita Mathur
Claudia M. Hillenbrand
Edward Hsiao
Geoffrey Schembri
Rodger Laurent
Eva A. Wegner
author_facet Anthony M. Sammel
Ivan Ho Shon
Daniel A. Moses
Stacey Fredericks
Gita Mathur
Claudia M. Hillenbrand
Edward Hsiao
Geoffrey Schembri
Rodger Laurent
Eva A. Wegner
author_sort Anthony M. Sammel
collection DOAJ
description Objective Giant cell arteritis (GCA) is characterized by cranial ischemia at diagnosis and late aortic structural disease. Repeated combined cranial and large‐vessel fluoro‐2‐deoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) scans were performed to assess the distribution of vasculitis activity over time and the relationship with clinical outcomes. Methods Patients were eligible if they were enrolled in a 64‐patient inception suspected GCA cohort in 2016 to 2017 and had a positive temporal artery biopsy and/or PET/CT scan at diagnosis. At five years, patients underwent a PET/CT scan, magnetic resonance aortogram, and clinical assessment. Scans were reported for overall metabolic disease activity and a visual FDG avidity grade at each vascular territory. Results Sixteen patients met inclusion criteria, and 11 attended the five‐year visit. Median age was 75 years, 73% were women, and all were in remission. At five years, 4 (36%) patients had aortic dilatation (range 40–43 mm), and five (45%) had globally active scans. Cranial artery activity resolved in all patients between diagnosis and five years, but aortitis developed in four patients who previously had PET‐inactive aortas. Disease‐modifying rheumatic drug (DMARD) use at five years was associated with scan inactivity (P = 0.02). There was a trend toward a higher mean aortic diameter in those with aortitis at five years (40.2 mm vs 36.0 mm, P = 0.06) but not those with aortitis at diagnosis. Conclusion Vasculitis activity changed from cranial and large vessel to exclusively large vessel by five years. This may explain the preponderance of early cranial and late aortic complications in GCA. The potential role of long‐term DMARDs to mitigate smoldering vasculitis warrants further study.
format Article
id doaj-art-9aa174a26f1f424a9a8bde9ea4ba9fdc
institution OA Journals
issn 2578-5745
language English
publishDate 2025-03-01
publisher Wiley
record_format Article
series ACR Open Rheumatology
spelling doaj-art-9aa174a26f1f424a9a8bde9ea4ba9fdc2025-08-20T01:55:58ZengWileyACR Open Rheumatology2578-57452025-03-0173n/an/a10.1002/acr2.70006Repeated Cranial and Large‐Vessel Positron Emission Tomography/Computed Tomography Scans and the Association With Structural Aortic Disease in Giant Cell Arteritis: A Five‐Year Observational StudyAnthony M. Sammel0Ivan Ho Shon1Daniel A. Moses2Stacey Fredericks3Gita Mathur4Claudia M. Hillenbrand5Edward Hsiao6Geoffrey Schembri7Rodger Laurent8Eva A. Wegner9Prince of Wales Hospital, Randwick, New South Wales, Australia, and University of New South Wales Sydney New South Wales AustraliaPrince of Wales Hospital, Randwick, New South Wales, Australia, and University of New South Wales Sydney New South Wales AustraliaPrince of Wales Hospital, Randwick, New South Wales, Australia, and University of New South Wales Sydney New South Wales AustraliaPrince of Wales Hospital Randwick New South Wales AustraliaPrince of Wales Hospital, Randwick, New South Wales, Australia, and University of New South Wales Sydney New South Wales AustraliaUniversity of New South Wales Sydney New South Wales AustraliaRoyal North Shore Hospital St Leonards New South Wales AustraliaRoyal North Shore Hospital St Leonards New South Wales AustraliaRoyal North Shore Hospital St Leonards New South Wales AustraliaPrince of Wales Hospital, Randwick, New South Wales, Australia, and University of New South Wales Sydney New South Wales AustraliaObjective Giant cell arteritis (GCA) is characterized by cranial ischemia at diagnosis and late aortic structural disease. Repeated combined cranial and large‐vessel fluoro‐2‐deoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) scans were performed to assess the distribution of vasculitis activity over time and the relationship with clinical outcomes. Methods Patients were eligible if they were enrolled in a 64‐patient inception suspected GCA cohort in 2016 to 2017 and had a positive temporal artery biopsy and/or PET/CT scan at diagnosis. At five years, patients underwent a PET/CT scan, magnetic resonance aortogram, and clinical assessment. Scans were reported for overall metabolic disease activity and a visual FDG avidity grade at each vascular territory. Results Sixteen patients met inclusion criteria, and 11 attended the five‐year visit. Median age was 75 years, 73% were women, and all were in remission. At five years, 4 (36%) patients had aortic dilatation (range 40–43 mm), and five (45%) had globally active scans. Cranial artery activity resolved in all patients between diagnosis and five years, but aortitis developed in four patients who previously had PET‐inactive aortas. Disease‐modifying rheumatic drug (DMARD) use at five years was associated with scan inactivity (P = 0.02). There was a trend toward a higher mean aortic diameter in those with aortitis at five years (40.2 mm vs 36.0 mm, P = 0.06) but not those with aortitis at diagnosis. Conclusion Vasculitis activity changed from cranial and large vessel to exclusively large vessel by five years. This may explain the preponderance of early cranial and late aortic complications in GCA. The potential role of long‐term DMARDs to mitigate smoldering vasculitis warrants further study.https://doi.org/10.1002/acr2.70006
spellingShingle Anthony M. Sammel
Ivan Ho Shon
Daniel A. Moses
Stacey Fredericks
Gita Mathur
Claudia M. Hillenbrand
Edward Hsiao
Geoffrey Schembri
Rodger Laurent
Eva A. Wegner
Repeated Cranial and Large‐Vessel Positron Emission Tomography/Computed Tomography Scans and the Association With Structural Aortic Disease in Giant Cell Arteritis: A Five‐Year Observational Study
ACR Open Rheumatology
title Repeated Cranial and Large‐Vessel Positron Emission Tomography/Computed Tomography Scans and the Association With Structural Aortic Disease in Giant Cell Arteritis: A Five‐Year Observational Study
title_full Repeated Cranial and Large‐Vessel Positron Emission Tomography/Computed Tomography Scans and the Association With Structural Aortic Disease in Giant Cell Arteritis: A Five‐Year Observational Study
title_fullStr Repeated Cranial and Large‐Vessel Positron Emission Tomography/Computed Tomography Scans and the Association With Structural Aortic Disease in Giant Cell Arteritis: A Five‐Year Observational Study
title_full_unstemmed Repeated Cranial and Large‐Vessel Positron Emission Tomography/Computed Tomography Scans and the Association With Structural Aortic Disease in Giant Cell Arteritis: A Five‐Year Observational Study
title_short Repeated Cranial and Large‐Vessel Positron Emission Tomography/Computed Tomography Scans and the Association With Structural Aortic Disease in Giant Cell Arteritis: A Five‐Year Observational Study
title_sort repeated cranial and large vessel positron emission tomography computed tomography scans and the association with structural aortic disease in giant cell arteritis a five year observational study
url https://doi.org/10.1002/acr2.70006
work_keys_str_mv AT anthonymsammel repeatedcranialandlargevesselpositronemissiontomographycomputedtomographyscansandtheassociationwithstructuralaorticdiseaseingiantcellarteritisafiveyearobservationalstudy
AT ivanhoshon repeatedcranialandlargevesselpositronemissiontomographycomputedtomographyscansandtheassociationwithstructuralaorticdiseaseingiantcellarteritisafiveyearobservationalstudy
AT danielamoses repeatedcranialandlargevesselpositronemissiontomographycomputedtomographyscansandtheassociationwithstructuralaorticdiseaseingiantcellarteritisafiveyearobservationalstudy
AT staceyfredericks repeatedcranialandlargevesselpositronemissiontomographycomputedtomographyscansandtheassociationwithstructuralaorticdiseaseingiantcellarteritisafiveyearobservationalstudy
AT gitamathur repeatedcranialandlargevesselpositronemissiontomographycomputedtomographyscansandtheassociationwithstructuralaorticdiseaseingiantcellarteritisafiveyearobservationalstudy
AT claudiamhillenbrand repeatedcranialandlargevesselpositronemissiontomographycomputedtomographyscansandtheassociationwithstructuralaorticdiseaseingiantcellarteritisafiveyearobservationalstudy
AT edwardhsiao repeatedcranialandlargevesselpositronemissiontomographycomputedtomographyscansandtheassociationwithstructuralaorticdiseaseingiantcellarteritisafiveyearobservationalstudy
AT geoffreyschembri repeatedcranialandlargevesselpositronemissiontomographycomputedtomographyscansandtheassociationwithstructuralaorticdiseaseingiantcellarteritisafiveyearobservationalstudy
AT rodgerlaurent repeatedcranialandlargevesselpositronemissiontomographycomputedtomographyscansandtheassociationwithstructuralaorticdiseaseingiantcellarteritisafiveyearobservationalstudy
AT evaawegner repeatedcranialandlargevesselpositronemissiontomographycomputedtomographyscansandtheassociationwithstructuralaorticdiseaseingiantcellarteritisafiveyearobservationalstudy